GENEVA, Dec. 2 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/US2025/030336) for "PONSEGROMAB FOR USE IN TREATING CACHEXIA IN CANCER PATIENTS" on May 21, 2025. With publication no. WO/2025/245200, the details related to the patent application was published on Nov 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BREEN, Danna Marie (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), FANG, Jarjieh (c/o Pfizer Inc.66 Hudson Boulevard EastNew York, New York 10001-2192), GROARKE, John David (c/o Pfizer Inc.610 Main StreetCambri...